NovaBay Pharmaceuticals (NBY) stock slides premarket after 102% surge — dilution risk back on radar

NovaBay Pharmaceuticals, Inc. shares slipped roughly 10% in early Monday trading, falling to $17.21 after finishing Friday at $19.16. This dip comes after a notable surge in the lightly traded stock on the NYSE American. https://stockanalysis.com/stocks/nby/

12 January 2026

Company hubNYSE:NBY

NovaBay Pharmaceuticals (NBY) (NBY) Stock News & Analysis

Follow the latest NovaBay Pharmaceuticals (NBY) (NBY) company news, earnings coverage and investor analysis from TechStock².

Save this hub to your TS2 Signalbook account.

Latest update: 12 January 2026
Articles in this hub: 3
Last 30 days: 0

What investors are watching

Earnings, guidance and financial performance
Valuation, trading activity and market sentiment
Strategy, catalysts and company-specific risks

Read latest coverage Prefer TechStock² in Google

NovaBay stock more than doubles on thin float — what to watch for NBY when markets reopen

Shares of NovaBay Pharmaceuticals, Inc. surged 102.54% to close Friday at $19.16, swinging between $9.69 and $19.95 during the session. Trading volume hit 9,996,659 shares. In after-hours trading, the stock reached $20.50.

12 January 2026

NYSE:NBY·Stock Market

NovaBay Pharmaceuticals stock jumps 102% — what to watch for NBY before Monday

Shares of NovaBay Pharmaceuticals, Inc soared Friday, closing up 102.5% at $19.16. The NYSE American stock will remain in focus when U.S. markets reopen Monday.

11 January 2026

NYSE:NBY·Pharmaceuticals·Stock Market